HUP0102075A2 - Stabil mitoxantron-oldatok, eljárás az előállításukra - Google Patents
Stabil mitoxantron-oldatok, eljárás az előállításukraInfo
- Publication number
- HUP0102075A2 HUP0102075A2 HU0102075A HUP0102075A HUP0102075A2 HU P0102075 A2 HUP0102075 A2 HU P0102075A2 HU 0102075 A HU0102075 A HU 0102075A HU P0102075 A HUP0102075 A HU P0102075A HU P0102075 A2 HUP0102075 A2 HU P0102075A2
- Authority
- HU
- Hungary
- Prior art keywords
- stable
- preparation
- solutions
- mitoxantrone
- mitoxantron
- Prior art date
Links
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001156 mitoxantrone Drugs 0.000 abstract 3
- 239000003381 stabilizer Substances 0.000 abstract 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229940037001 sodium edetate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A találmány mitoxantron-oldatokra vonatkozik, amelyek a mitoxantronhatóanyag {1,4-dihidro-5,8-bisz[[2-[(2-hidroxietil)-amino)etil]-amino]-antrakinon-hidroklorid} mellett stabilizátort tartalmaznak ésszulfit-vegyületektől mentesek. A találmány szerinti mitoxantron-oldatok stabilizátorként 0,001-0,15 % nátrium-edetátot tartalmaznak. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19818802A DE19818802A1 (de) | 1998-04-27 | 1998-04-27 | Stabile Mitoxantron-Lösungen |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0102075A2 true HUP0102075A2 (hu) | 2002-05-29 |
HUP0102075A3 HUP0102075A3 (en) | 2002-10-28 |
Family
ID=7865948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0102075A HUP0102075A3 (en) | 1998-04-27 | 1999-04-01 | Stable mitoxantron solutions, process for their preparation |
Country Status (18)
Country | Link |
---|---|
US (1) | US6143795A (hu) |
EP (1) | EP1073469B1 (hu) |
JP (1) | JP2002512981A (hu) |
CN (1) | CN1195548C (hu) |
AR (1) | AR018198A1 (hu) |
AT (1) | ATE282431T1 (hu) |
AU (1) | AU744502B2 (hu) |
BG (1) | BG64767B1 (hu) |
BR (1) | BR9909981A (hu) |
CA (1) | CA2270004C (hu) |
CO (1) | CO5021217A1 (hu) |
DE (2) | DE19818802A1 (hu) |
HK (1) | HK1036012A1 (hu) |
HU (1) | HUP0102075A3 (hu) |
NZ (1) | NZ507407A (hu) |
RU (1) | RU2219917C2 (hu) |
TW (1) | TWI224003B (hu) |
WO (1) | WO1999055375A1 (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0005703D0 (en) * | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
EP1615646B2 (en) | 2003-04-08 | 2022-07-27 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
CN102397561B (zh) * | 2011-09-26 | 2013-03-06 | 沈阳药科大学 | 米托蒽醌作为淋巴示踪剂的应用 |
JP5589110B1 (ja) * | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
CN107149592B (zh) * | 2017-06-23 | 2019-10-08 | 沈阳天邦药业有限公司 | 具有淋巴靶向功能的生物自组装纳米晶注射剂及制备方法 |
CN113730603B (zh) * | 2020-05-27 | 2023-01-24 | 深圳华润九创医药有限公司 | 米托蒽醌制剂在制备诊治与甲状腺切除相关的疾病的药物中的应用 |
CN114601791B (zh) * | 2020-12-08 | 2023-09-19 | 成都倍特药业股份有限公司 | 一种盐酸米托蒽醌液体制剂及其制备方法 |
CN114732807A (zh) * | 2022-03-27 | 2022-07-12 | 苏州大学 | 米托蒽醌在制备预防或治疗急性移植物抗宿主病药物中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3248291A (en) * | 1963-08-19 | 1966-04-26 | Hoffmann La Roche | Stabilized thioxanthene derivatives and method of using the same |
ES2033247T3 (es) * | 1986-03-07 | 1993-03-16 | American Cyanamid Company | Metodo para preparar una composicion farmaceutica a base de un compuesto antraquinonico. |
IL83086A (en) * | 1987-07-06 | 1991-03-10 | Teva Pharma | Stable,injectable solutions of vincristine salts |
DE3825374A1 (de) * | 1988-07-26 | 1990-02-01 | Schwendener Reto Dipl Apotheke | Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren |
WO1994013274A1 (en) * | 1992-12-10 | 1994-06-23 | Abbott Laboratories | Stabilized catecholamine solutions |
FR2758264B1 (fr) * | 1997-01-16 | 1999-03-26 | Charles Dumontet | Compositions medicamenteuses contenant de l'edta ou un de ses derives pour la prevention de la toxicite cutanee et sous-cutanee des anthracyclines et de leurs derives |
-
1998
- 1998-04-27 DE DE19818802A patent/DE19818802A1/de not_active Ceased
-
1999
- 1999-04-01 JP JP2000545572A patent/JP2002512981A/ja active Pending
- 1999-04-01 BR BR9909981-0A patent/BR9909981A/pt not_active Application Discontinuation
- 1999-04-01 AT AT99916906T patent/ATE282431T1/de not_active IP Right Cessation
- 1999-04-01 NZ NZ507407A patent/NZ507407A/xx unknown
- 1999-04-01 HU HU0102075A patent/HUP0102075A3/hu unknown
- 1999-04-01 CN CNB998055794A patent/CN1195548C/zh not_active Expired - Fee Related
- 1999-04-01 RU RU2000129666/14A patent/RU2219917C2/ru active
- 1999-04-01 WO PCT/EP1999/002290 patent/WO1999055375A1/de active IP Right Grant
- 1999-04-01 DE DE59911099T patent/DE59911099D1/de not_active Expired - Fee Related
- 1999-04-01 AU AU35225/99A patent/AU744502B2/en not_active Ceased
- 1999-04-01 EP EP99916906A patent/EP1073469B1/de not_active Expired - Lifetime
- 1999-04-07 CO CO99020294A patent/CO5021217A1/es unknown
- 1999-04-23 TW TW088106569A patent/TWI224003B/zh not_active IP Right Cessation
- 1999-04-26 CA CA002270004A patent/CA2270004C/en not_active Expired - Fee Related
- 1999-04-26 US US09/299,131 patent/US6143795A/en not_active Expired - Fee Related
- 1999-04-27 AR ARP990101932A patent/AR018198A1/es unknown
-
2000
- 2000-10-12 BG BG104850A patent/BG64767B1/bg unknown
-
2001
- 2001-09-24 HK HK01106731A patent/HK1036012A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2270004A1 (en) | 1999-10-27 |
WO1999055375A1 (de) | 1999-11-04 |
AU3522599A (en) | 1999-11-16 |
JP2002512981A (ja) | 2002-05-08 |
AR018198A1 (es) | 2001-10-31 |
RU2219917C2 (ru) | 2003-12-27 |
CN1298310A (zh) | 2001-06-06 |
CN1195548C (zh) | 2005-04-06 |
NZ507407A (en) | 2002-08-28 |
CA2270004C (en) | 2004-06-01 |
AU744502B2 (en) | 2002-02-28 |
TWI224003B (en) | 2004-11-21 |
EP1073469B1 (de) | 2004-11-17 |
HK1036012A1 (en) | 2001-12-21 |
BR9909981A (pt) | 2000-12-26 |
CO5021217A1 (es) | 2001-03-27 |
BG64767B1 (bg) | 2006-03-31 |
US6143795A (en) | 2000-11-07 |
DE19818802A1 (de) | 1999-10-28 |
DE59911099D1 (de) | 2004-12-23 |
BG104850A (en) | 2001-05-31 |
ATE282431T1 (de) | 2004-12-15 |
EP1073469A1 (de) | 2001-02-07 |
HUP0102075A3 (en) | 2002-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302086A2 (hu) | Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására | |
BR0108893A (pt) | Composição farmacêutica, composto e processo de preparação de compostos | |
BR9503386A (pt) | Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina | |
BR9908545A (pt) | Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica | |
HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
YU39800A (sh) | Derivati sulfonamida kao pro-lekovi inhibitora aspartil proteaze | |
IL145429A0 (en) | N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same | |
BR0015567A (pt) | Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos | |
BR9911160A (pt) | Ciclosporinas | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
UY27548A1 (es) | Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas | |
BR0214199A (pt) | Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração | |
BR9814549A (pt) | "composição farmacêutica contendo cloridrato de bupropion e um estabilizador" | |
BR0211063A (pt) | Sais de derivados anticonvulsivantes | |
SE0102440D0 (sv) | New compound | |
BR0101230A (pt) | Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina | |
HUP0102075A2 (hu) | Stabil mitoxantron-oldatok, eljárás az előállításukra | |
ATE440838T1 (de) | Pharmazeutisch aktive sulfonylaminosäurederivate | |
UA41978C2 (uk) | N-метил-n-[(1s)-1-феніл-2-((3s)-3-гідроксипіролідин-1-іл)етил]-2,2- дифенілацетамід гідрохлорид, спосіб його отримання та фармацевтична композиція | |
DE69819539D1 (de) | Antithrombotische mittel | |
BR9611642A (pt) | Compostos composição farmacéutica e processo para a preparação de compostos | |
EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
BR0208504A (pt) | Composição farmacêutica estável de pravastatina | |
IT1306147B1 (it) | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali | |
BR9915323A (pt) | Derivados pirimidina e processos para sua preparação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |